Publisher's Synopsis
The revised and updated second edition of this clinical reference text provides complete information on the clinical pharmacology, clinical indications, use, and relative costs of all cardiac and cardiovascular drugs available today. The contributors offer current, definitive guidelines on the use of new and standard drugs in treatment of common conditions and detail the new drug therapies that now enable physicians to abort myocardial infarction, limit infarct size, prevent stroke, and diminish or reverse atherosclerosis. New areas covered in the second edition include thrombolytic and adjunctive drug therapy for acute myocardial infarction; drug therapy after cardiac transplantation; new antiarrhythmic drugs; and angiotensin-converting enzyme inhibitors.
